Effect of supplementation in treatment of women with polycystic ovary syndrome of IVF candidate

Phase 3

• Conditions: Polycystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT201704245623N113
• Lead Sponsor: Vice chancellor for research, Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Patients with PCOS of IVF candidate according to Rotterdam criteria
Aged 18 to 40 years

Exclusion Criteria

Pregnant women
Participants with elevated levels of prolactin
Thyroid disorder
Endocrine diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expressed levels of PPAR-?. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: PCR.;Expressed levels of GLUT-1. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: PCR.

Secondary Outcome Measures

Name	Time	Method
Expressed levels of Lp(a) gene. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: PCR.;Expressed levels of LDLR gene. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: PCR.